US-Israeli airstrikes today hit one of the largest pharmaceutical companies in Iran which produces anaesthetic and cancer drugs, the Iranian government says.
“During the US and Zionist regime attacks on civilian centers, on the morning of Tuesday, one of the largest companies producing anti-cancer, anaesthetic and specialized medicines was damaged and the drug production line was damaged,” the government says in a post on X.
The pharmaceutical company is named as Tofigh Daru Research & Engineering Company, which is owned by the Social Security Investment Company, a state-run holding firm.
On LinkedIn, Tofigh Daru says it develops and produces active pharmaceutical ingredients “in the anticancer, narcotics, cardiovascular to immunomodulatory segments.”
Iran has long faced chronic shortages of medicines, partly due to UN sanctions imposed over its nuclear program. The sanctions have crippled essential trade services such as banking, while scaring off drug companies from doing business in Iran, even though humanitarian products are exempt.
Help us report truthfully on social media
As a multimedia journalist, my job is to take the quality, fact-based journalism produced by The Times of Israel newsroom and make it accessible across every platform — from Instagram posts to podcasts to short-form videos.
This is how many, especially young people, consume news these days. But misinformation is rampant on social media. Our team at ToI produces accurate, responsible short-form reporting on Israel and the Jewish world.
If you believe in the importance of factual social media journalism, please consider joining our reader support group, The Times of Israel Community. Your financial support is essential to sustain responsible multimedia reporting.
— Gabriella Jacobs, multimedia journalist
Support our work
Support our work
Already a member? Sign in to stop seeing this
You're a dedicated reader
We’re really pleased that you’ve read X Times of Israel articles in the past month.
That’s why we started the Times of Israel - to provide discerning readers like you with must-read coverage of Israel and the Jewish world.
So now we have a request. Unlike other news outlets, we haven’t put up a paywall. But as the journalism we do is costly, we invite readers for whom The Times of Israel has become important to help support our work by joining The Times of Israel Community.
For as little as $6 a month you can help support our quality journalism while enjoying The Times of Israel AD-FREE, as well as accessing exclusive content available only to Times of Israel Community members.
Thank you,
David Horovitz, Founding Editor of The Times of Israel
Join Our Community
Join Our Community
Already a member? Sign in to stop seeing this
From the Liveblog of
Tuesday, March 31, 2026
Add ToI as a Preferred Source on Google
